The Feds just started charging drug company executives for price fixing
Advertisement
Flickr/Kiran Foster
Advertisement
Bloomberg is reporting that the former president and former CEO of Heritage Pharmaceuticals were both charged Monday.
In November, Bloomberg reported that Federal prosecutors may start bringing down charges regarding price fixing as part of a larger investigation into generic drugmakers. EpiPen-maker Mylan and Teva Pharmaceuticals are among the other companies under investigation.
This story is developing.
Next StoryAdvertisement
I spent 2 weeks in India. A highlight was visiting a small mountain town so beautiful it didn't seem real. 
I quit McKinsey after 1.5 years. I was making over $200k but my mental health was shattered.
Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
World Liver Day 2024: 10 Foods that are necessary for a healthy liver
Essential tips for effortlessly renewing your bike insurance policy in 2024
Indian Railways to break record with 9,111 trips to meet travel demand this summer, nearly 3,000 more than in 2023
India's exports to China, UAE, Russia, Singapore rose in 2023-24
A case for investing in Government securities
